Biodelivery Sciences International (BDSI) Valuation Rose While Foresite Capital Management Ii Lowered by $457,500 Its Holding; Acceleron Pharma (XLRN) Valuation Declined While Foresite Capital Management Ii Has Lowered Its Stake

Foresite Capital Management Ii Llc decreased its stake in Acceleron Pharma Inc. (XLRN) by 4.84% based on its latest 2018Q4 regulatory filing with the SEC. Foresite Capital Management Ii Llc sold 10,666 shares as the company’s stock declined 13.57% while stock markets rallied.


Read all

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.